Patel Sushil
CIK 0001860609
Chief Strategy OfficerDirector
Filings
22
Latest May 20, 2026
Issuers covered
2
Showing
22 of 22
Page 1
Track record
11 of 12 open-market trades scored (92% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 11 | 55% | +1.3% | +3.2% | +16.5% | -29.9% |
| 90 days | 11 | 55% | +1.1% | +5.6% | +42.0% | -46.7% |
| 180 days | 11 | 73% | +7.6% | +7.1% | +69.1% | -81.4% |
| 365 days | 10 | 70% | +22.3% | +17.6% | +63.4% | -27.3% |
Issuers
Companies where Patel Sushil has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| REPL | Replimune Group, Inc. | 14 | May 20, 2026 |
| RVMD | Revolution Medicines, Inc. | 8 | Jun 30, 2025 |
All filings
22 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|